查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599299

全球病毒學檢體採集市場：按產品、檢體和最終用戶分類 - 預測 2025-2030 年

Virology Specimen Collection Market by Product (Blood Collection Kits, Specimen Collection Tubes, Swabs), Sample (Blood Samples, Cervical Samples, Nasal Samples), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年病毒學檢體體採集市場​​價值為26.8億美元，預計到2024年將達到33.1億美元，複合年成長率為23.89%，預計到2030年將達到120.5億美元。

病毒學檢體體採集市場​​的定義是其在採集診斷病毒感染所需樣本（例如拭子、血液、尿液和唾液）方面的作用。這個市場需要準確的診斷工具來應對大流行的準備和常規病毒學。其應用範圍從臨床診斷和藥物發現到流行病學研究，影響醫院、診斷實驗室和研究機構。該領域的促進因素包括病毒爆發的增加、對感染疾病的認知提高以及收集方法的進步。自動化、人工智慧以及儲存和運輸技術的改進代表了重大商機。透過利用這些進步，公司可以期待強勁的成長。建議重點關注提高樣品完整性和整合數位診斷平台。儘管存在成長機會，但市場成長面臨挑戰，例如高成本、嚴格的法律規範以及與運輸和儲存檢體相關的物流複雜性。為了克服這些問題，企業應優先考慮旨在簡化供應鏈的具有成本效益的創新和夥伴關係。

主要市場統計
基準年[2023] 26.8億美元
預測年份 [2024] 33.1億美元
預測年份 [2030] 120.5億美元
複合年成長率（%） 23.89%

新的商機在於開發提供便利性和可靠性的快速檢體採集套件，特別是在資源有限的環境中。投資可攜式診斷設備，最大限度地減少對複雜基礎設施的需求，也可以使市場參與者脫穎而出。將檢體採集與綜合診斷服務聯繫起來的遠端醫療和數位健康解決方案的作用也是一個有前途的發展途徑。技術創新必須著重於提高檢體分析的便攜性、準確性和速度。市場競爭激烈且快速發展，需要不斷適應新技術和客戶需求。透過專注於能夠快速應對突發衛生事件的可擴展解決方案，公司可以鞏固其在全球病毒學領域的作用。這種策略創新和合作關係使企業不僅能夠滿足當前的需求，還能有效應對未來不可預見的挑戰。

市場動態：快速發展的病毒學檢體採集市場的關鍵市場洞察

供需的動態交互作用正在改變病毒學檢體體採集市場​​。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 病毒性疾病的流行和新病原體的出現
    • 捐血增加
    • 政府為維護檢體採集安全而製定的準則
  • 市場限制因素
    • 對檢體採集、處理和運輸程序不完善的擔憂
  • 市場機會
    • 來自公共和私人機構的強大財政支持
    • 抗病毒療法的開發進展
  • 市場挑戰
    • 病毒學檢體採集技術高成本檢體

波特檢體力：駕馭病毒學檢體採集市場​​的策略工具

波特的五力架構是了解病毒學檢體體採集市場​​競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解病毒學檢體採集市場​​的外部影響

外部宏觀環境因素在塑造病毒學檢體體採集市場​​的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解病毒學檢體採集市場​​的競爭格局

對病毒學檢體採集市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣病毒學檢體採集市場供應商的績效評估

FPNV定位矩陣是評估病毒學檢體體採集市場​​供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，規劃病毒學檢體採集市場​​的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對病毒學檢體採集市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 病毒性疾病的傳播和新病原體的出現
      • 捐血增加
      • 政府制定指導方針以確保檢體採集安全
    • 抑制因素
      • 對收集、處理和運輸程序不完善的擔憂
    • 機會
      • 來自公私機構的雄厚資金
      • 抗病毒療法的發展進展
    • 任務
      • 病毒學檢體檢體技術高成本
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章病毒學檢體採集市場​​：依產品

  • 血液採集套件
  • 檢體採集管
  • 棉花棒
  • 病毒運輸媒介

第7章 病毒學檢體體採集市場​​樣本

  • 血液樣本
  • 子宮頸樣本
  • 鼻腔樣本
  • 鼻咽樣本
  • 口腔樣本
  • 喉嚨樣本

第8章病毒學檢體採集市場​​：依最終使用者分類

  • 診斷中心
  • 醫院/診所

第9章美洲病毒學檢體採集市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區病毒學檢檢體採集市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲病毒學檢檢體採集市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Element Materials Technology Group Limited
  • Hardy Diagnostics
  • HiMedia Laboratories, LLC
  • LABORATORY ALLIANCE OF CENTRAL NEW YORK, LLC
  • Laboratory Corporation of America Holdings
  • Medical Wire & Equipment
  • Merck KGaA
  • Omega Bio-tek, Inc.
  • PHARMIWEB.COM LIMITED
  • Puritan Medical Products
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
Product Code: MRR-8201ABF20F0B

The Virology Specimen Collection Market was valued at USD 2.68 billion in 2023, expected to reach USD 3.31 billion in 2024, and is projected to grow at a CAGR of 23.89%, to USD 12.05 billion by 2030.

The market for virology specimen collection is defined by its role in acquiring samples necessary for diagnosing viral infections, which include swabs, blood, urine, and saliva. This market is indispensable due to the critical need for accurate diagnostic tools in both pandemic preparedness and routine virology. Its applications range from clinical diagnostics and drug discovery to epidemiological research, impacting hospitals, diagnostic labs, and research institutes. Driving factors in this sector include the rise in viral outbreaks, heightened awareness about infectious diseases, and advancements in collection methodologies. The use of automation, AI, and improved storage and transport technologies presents significant opportunities. For businesses, tapping into these advancements can yield robust growth; a focus on enhancing sample integrity and integrating digital diagnostic platforms is advised. Despite opportunities, market growth faces challenges such as high costs, stringent regulatory frameworks, and logistical complexities associated with specimen transport and storage. To overcome these, businesses should prioritize cost-effective innovations and partnerships aimed at enhancing supply chain efficiency.

KEY MARKET STATISTICS
Base Year [2023] USD 2.68 billion
Estimated Year [2024] USD 3.31 billion
Forecast Year [2030] USD 12.05 billion
CAGR (%) 23.89%

Emerging opportunities lie in developing rapid specimen collection kits that offer convenience and reliability, particularly in resource-constrained settings. Investing in portable diagnostic devices that minimize the need for complex infrastructure can also differentiate market players. The role of telemedicine and digital health solutions in linking specimen collection with comprehensive diagnostic services is another promising avenue for development. Innovation must focus on improving portability, accuracy, and speed of specimen analysis. The market is competitive and rapidly evolving, necessitating constant adaptation to new technologies and customer needs. Companies will benefit from focusing on scalable solutions that can swiftly respond to health emergencies, thus solidifying their role in the global virology landscape. These strategic innovations and collaborations will position businesses to not only meet current demands but also address unforeseen future challenges effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Virology Specimen Collection Market

The Virology Specimen Collection Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of viral diseases and emergence of newer pathogens
    • Growing number of blood donations
    • Government set guidelines to maintain safety of specimen collection
  • Market Restraints
    • Concerns regarding inadequate procedures for collection, handling, transport
  • Market Opportunities
    • Robust funding from the public and private agencies
    • Development progress in antiviral therapeutics
  • Market Challenges
    • High cost of virology specimen collection technologies

Porter's Five Forces: A Strategic Tool for Navigating the Virology Specimen Collection Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Virology Specimen Collection Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Virology Specimen Collection Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Virology Specimen Collection Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Virology Specimen Collection Market

A detailed market share analysis in the Virology Specimen Collection Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Virology Specimen Collection Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Virology Specimen Collection Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Virology Specimen Collection Market

A strategic analysis of the Virology Specimen Collection Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Virology Specimen Collection Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Becton, Dickinson and Company, Element Materials Technology Group Limited, Hardy Diagnostics, HiMedia Laboratories, LLC, LABORATORY ALLIANCE OF CENTRAL NEW YORK, LLC, Laboratory Corporation of America Holdings, Medical Wire & Equipment, Merck KGaA, Omega Bio-tek, Inc., PHARMIWEB.COM LIMITED, Puritan Medical Products, Quidel Corporation, Thermo Fisher Scientific Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Virology Specimen Collection Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Blood Collection Kits, Specimen Collection Tubes, Swabs, and Viral Transport Media.
  • Based on Sample, market is studied across Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Oral Samples, and Throat Samples.
  • Based on End User, market is studied across Diagnostic Centers and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of viral diseases and emergence of newer pathogens
      • 5.1.1.2. Growing number of blood donations
      • 5.1.1.3. Government set guidelines to maintain safety of specimen collection
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns regarding inadequate procedures for collection, handling, transport
    • 5.1.3. Opportunities
      • 5.1.3.1. Robust funding from the public and private agencies
      • 5.1.3.2. Development progress in antiviral therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. High cost of virology specimen collection technologies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Virology Specimen Collection Market, by Product

  • 6.1. Introduction
  • 6.2. Blood Collection Kits
  • 6.3. Specimen Collection Tubes
  • 6.4. Swabs
  • 6.5. Viral Transport Media

7. Virology Specimen Collection Market, by Sample

  • 7.1. Introduction
  • 7.2. Blood Samples
  • 7.3. Cervical Samples
  • 7.4. Nasal Samples
  • 7.5. Nasopharyngeal Samples
  • 7.6. Oral Samples
  • 7.7. Throat Samples

8. Virology Specimen Collection Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Hospitals & Clinics

9. Americas Virology Specimen Collection Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Virology Specimen Collection Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Virology Specimen Collection Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Becton, Dickinson and Company
  • 3. Element Materials Technology Group Limited
  • 4. Hardy Diagnostics
  • 5. HiMedia Laboratories, LLC
  • 6. LABORATORY ALLIANCE OF CENTRAL NEW YORK, LLC
  • 7. Laboratory Corporation of America Holdings
  • 8. Medical Wire & Equipment
  • 9. Merck KGaA
  • 10. Omega Bio-tek, Inc.
  • 11. PHARMIWEB.COM LIMITED
  • 12. Puritan Medical Products
  • 13. Quidel Corporation
  • 14. Thermo Fisher Scientific Inc.
  • 15. Trinity Biotech PLC

LIST OF FIGURES

  • FIGURE 1. VIROLOGY SPECIMEN COLLECTION MARKET RESEARCH PROCESS
  • FIGURE 2. VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. VIROLOGY SPECIMEN COLLECTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. VIROLOGY SPECIMEN COLLECTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VIROLOGY SPECIMEN COLLECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VIROLOGY SPECIMEN COLLECTION MARKET DYNAMICS
  • TABLE 7. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD COLLECTION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SPECIMEN COLLECTION TUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SWABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY CERVICAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY NASOPHARYNGEAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY ORAL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY THROAT SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY SAMPLE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM VIROLOGY SPECIMEN COLLECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. VIROLOGY SPECIMEN COLLECTION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. VIROLOGY SPECIMEN COLLECTION MARKET, FPNV POSITIONING MATRIX, 2023